Clinical Trials Related to Hepatocellular Carcinoma

Related studies linked through entity extraction aliases.

A Retrospective Study of Safety and Efficacy of Locoregional Therapies Combined With Anti-VEGF/TKIs and Immune Checkpoint Inhibitors for All Comers of Intention-to-treat Patients With Hepatocellular Carcinoma Beyond UCSF Criteria Before Liver Transplantation

Status: NOT_YET_RECRUITING
Phase: N/A

A Phase III Randomized Study of TACE Plus an Oral Triple-Agent Cocktail Versus TACE Plus First-Line Targeted Immunotherapy in Unresectable Hepatocellular Carcinoma

Status: NOT_YET_RECRUITING
Phase: PHASE2/PHASE3

Survival Analysis of Surgical Resection Versus Observation in Patients With Initially uHCC Achieving CR After Systemic Therapy

Status: ENROLLING_BY_INVITATION
Phase: N/A

The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas

Status: RECRUITING
Phase: PHASE2

Transarterial Chemoembolization With Low-Dose Bevacizumab Plus Atezolizumab as First-Line Treatment for Unresectable Hepatocellular Carcinoma

Status: NOT_YET_RECRUITING
Phase: NA

JMT106 Injection in the Treatment of Advanced Solid Tumors

Status: RECRUITING
Phase: PHASE1

SBRT Plus Systemic Therapy vs Systemic Therapy Alone in BCLC C Hepatocellular Carcinoma

Status: RECRUITING
Phase: PHASE2

New Diagnostic Criteria in the Evaluation Response to Ablation Treatment of Hepatocellular Carcinoma Nodules

Status: NOT_YET_RECRUITING
Phase: N/A

Study of ACC-1898 in Adult Participants With Advanced Solid Tumors

Status: NOT_YET_RECRUITING
Phase: PHASE1

A Single-arm Phase II Clinical Study Investigating the Safety and Efficacy of Carbon Ion Radiotherapy in Patients With Hepatocellular Carcinoma Previously Treated With Transarterial Radioembolization (TARE)

Status: RECRUITING
Phase: NA

A Phase II Single-Arm Clinical Study to Evaluate the Efficacy and Safety of Carbon Ion Radiotherapy With Atezolizumab and Bevacizumab Combination Therapy in Patients With Advanced Hepatocellular Carcinoma

Status: RECRUITING
Phase: PHASE2

Study on the Therapeutic Effect of Different Infusion Times of Tislelizumab on Postoperative High-risk Hepatocellular Carcinoma

Status: RECRUITING
Phase: NA

Deep Learning-Based Multidimensional Body Composition Mapping for Outcome Prediction in HCC Patients Undergoing TACE

Status: RECRUITING
Phase: N/A

Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.

Status: RECRUITING
Phase: PHASE1/PHASE2

Maintenance Zanzalintinib and Durvalumab in Participants With Advanced Hepatocellular Cancer

Status: NOT_YET_RECRUITING
Phase: PHASE2

Cytokine Armored GPC3 Specific Chimeric Antigen Receptor Expressing T-cells in Adults With Solid Tumors

Status: NOT_YET_RECRUITING
Phase: PHASE1

Patient Preference for Subcutaneous vs. Intravenous Immune Therapy

Status: RECRUITING
Phase: PHASE2

Safety and Efficacy of Atezolizumab-Bevacizumab Versus Tyrosin Kinase Inhibitors in Patients With Liver Cirrhosis

Status: COMPLETED
Phase: N/A

Enhanced Radiofrequency Ablation for Recurrent HCC Post-TACE Using Twin Internally Cooled-Perfusion Electrodes

Status: COMPLETED
Phase: NA

Immunogenomic Dynamics and Biomarkers in Patients With Hepatocellular Carcinoma Receiving Immunotherapy

Status: RECRUITING
Phase: N/A